{"meta":{"query_hash":"4aed924b31d0","filters":{"venue":"Cytokines Cellular & Molecular Therapy"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4aed924b31d0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cytokines+Cellular+%26+Molecular+Therapy"},"results":[{"id":"W2039946232","doi":"10.1080/13684730412331302063","title":"Intracellular cytokine analysis of interferon-? in T cells of patients with chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council Canada","keywords":"Cytokine; Myeloid leukemia; Immunology; Interferon; Intracellular; Medicine; Myeloid; Leukemia; Cancer research; Biology; Cell biology","score_opus":0.009742204197778038,"score_gpt":0.21810943416776749,"score_spread":0.20836722996998944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039946232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993887,0.000299038,0.00006963295,0.000008090643,0.0000037876603,0.000011635348,0.00005380228,0.0000018246122,0.000163439],"genre_scores_gemma":[0.99946386,0.000118839314,0.00009453242,0.000022232583,0.00001521487,0.00001899428,0.00015464915,0.000001166584,0.00011051497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980265,0.00004851948,0.000025960777,0.000045105473,0.000037583737,0.000040199444],"domain_scores_gemma":[0.99966836,0.00008663155,0.00010861442,0.000018091476,0.000037893,0.00008044042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021149177,0.00034911293,0.00040580524,0.00063440023,0.00030315862,0.00032374592,0.00008932532,0.0003127774,0.00075959024],"category_scores_gemma":[0.00087046943,0.00014915217,0.00015592227,0.00033998548,0.00022923246,0.00015967803,0.0001401149,0.0002625946,0.00017939194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00444067,0.00027693255,0.91080105,0.00009916593,0.00006528896,0.0016364338,0.00072000787,0.00017141429,0.06565431,0.00004198233,0.000132694,0.015960118],"study_design_scores_gemma":[0.00012852896,0.0034456889,0.9817391,0.000015835021,0.00009060752,0.004208615,0.00034581887,0.00033534682,0.008701712,0.00003923648,0.00093912,0.000010515634],"about_ca_topic_score_codex":0.00049016956,"about_ca_topic_score_gemma":0.00040726026,"teacher_disagreement_score":0.00075959024,"about_ca_system_score_codex":0.00020452369,"about_ca_system_score_gemma":0.00012482703,"threshold_uncertainty_score":0.0025411248},"labels":[],"label_agreement":null},{"id":"W2073019201","doi":"10.1080/13684730210002319","title":"Increased IFN-? synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Cytokine; Myeloid leukemia; Immunology; Tyrosine-kinase inhibitor; White blood cell; Myeloid; Stem cell; Internal medicine; Cancer; Biology","score_opus":0.014267104526376168,"score_gpt":0.23014121510386867,"score_spread":0.2158741105774925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073019201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940646,0.00025201068,0.000055863977,0.000018839382,0.0000056660565,0.000006839798,0.00005010027,0.0000025508004,0.00020173857],"genre_scores_gemma":[0.99925965,0.00012561618,0.00007440937,0.000053680687,0.000018518618,0.0000120949435,0.00020138103,0.0000020327911,0.00025268595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998634,0.00002777987,0.000017354349,0.000027705182,0.0000251411,0.000038594615],"domain_scores_gemma":[0.9996834,0.00008976943,0.000100510915,0.000020896228,0.00003207752,0.0000734846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001468229,0.00029384144,0.00038915692,0.00044988308,0.00037995228,0.00041656045,0.000084790256,0.0003014492,0.0014257365],"category_scores_gemma":[0.0008154678,0.00019518108,0.00016413192,0.00025064015,0.00022349627,0.00017957215,0.00014645238,0.00031401764,0.0003522522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061603026,0.00035477048,0.7371027,0.00011959153,0.00011167586,0.0033687078,0.0011390948,0.00030980422,0.22388777,0.00008179611,0.0005019477,0.02686201],"study_design_scores_gemma":[0.0002583357,0.0035672586,0.96977127,0.00002230233,0.00013848036,0.00873858,0.00037125417,0.00055856595,0.013446878,0.00007334625,0.0030340352,0.000019739407],"about_ca_topic_score_codex":0.00055462896,"about_ca_topic_score_gemma":0.00047621323,"teacher_disagreement_score":0.0014257365,"about_ca_system_score_codex":0.00020664638,"about_ca_system_score_gemma":0.00012050006,"threshold_uncertainty_score":0.0047695637},"labels":[],"label_agreement":null}]}